Assessment of the Benefits and Cost-Effectiveness of Population-Based Breast Cancer Screening in Urban China: A Model-Based Analysis

Jing Wang ¹ , Marcel J.W. Greuter ^2,3, Senshuang Zheng ¹, Daniëlle W.A. van Veldhuizen ¹, Karin M. Vermeulen ¹, Yuan Wang ^4,5, Wenli Lu ^4,5 * , Geertruida H. de Bock ¹

Cited by CrossRef:

1- Jiang J, Jiang S, Ahumada-Canale A, Chen Z, Si L, Jiang Y, Yang L, Gu Y. Breast Cancer Screening Should Embrace Precision Medicine: Evidence by Reviewing Economic Evaluations in China. Adv Ther. 2023;40(4):1393 [Crossref]

2- Luo C, Wang L, Zhang Y, Lu M, Lu B, Cai J, Chen H, Dai M. Advances in breast cancer screening modalities and status of global screening programs. Chronic Diseases and Translational Medicine. 2022;8(2):112 [Crossref]

3- Lim Y, Lim Z, Ho P, Li J. Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives. Cancers. 2022;14(17):4218 [Crossref]

4- Icanervilia A, van der Schans J, Cao Q, de Carvalho A, Cordova-Pozo K, At Thobari J, Postma M, van Asselt A. Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review. J Glob Health. 2022;12 [Crossref]

Submit Your Paper Archive